Salvia Investment GmbH
Salvia Investment GmbH, 10% owner at Bambusa Therapeutics, Inc., has 1 open-market purchase worth $6,000,000 in company stock reported to the SEC in the last two years. The latest filing was reported on 2026-11-02.
In plain English
- A 10%+ shareholder bought $6,000,000 of Bambusa Therapeutics, Inc. stock with their own money. 1 other insider also bought in the same week, so it is not a one-person bet. (2026-11-02)
Filings
| Reported | Stock | What | Amount | Source |
|---|
| 2026-11-02 | BBTX
Bambusa Therapeutics, Inc. | Bought | $6,000,000 | SEC filing |
All insider buys · Legends · Executives
TradeTrack shows public SEC filings for general information. It is not investment advice, an offer or a recommendation. Insiders buy and sell for many reasons, past results do not predict future results, and you can lose money.